IN VIVO INOCULATION OF GBM CELLS IN RATS AND TREATMENT WITH RUXOLITINIB

IN VIVO INOCULATION OF GBM CELLS IN RATS AND TREATMENT WITH RUXOLITINIB

GlioStat (patent pending) denotes an invention that addresses the current deficiencies of glioblastoma (GBM) chemotherapy by developing a molecularly imprinted drug reservoir that is specifically designed for post-surgical recovery. The goal of our research was to guarantee the long-term release of...

Full description

Bibliographic Details
Main Authors: Ioan-Alexandru Florian, Valeriu-Sergiu Susman, Bodoki Ede, Olga Soritau, Petru-Cosmin Pestean, Bogdan-Cezar Iacob, Alexandra-Iulia Baraian, Andrei Buruiana, Ioan-Stefan Florian
Format: Article
Language:English
Published: London Academic Publishing 2024-11-01
Series:Romanian Neurosurgery
Subjects:
glioblastoma (GBM)
Ruxolitinib (RUX)
molecularly imprinted polymers (MIP)
in vivo studies
GlioStat
microscooping
Online Access:http://journals.lapub.co.uk/index.php/roneurosurgery/article/view/2820

Internet

http://journals.lapub.co.uk/index.php/roneurosurgery/article/view/2820

Similar Items